Clinical Trials

Any further development efforts for either of our product candidates is dependent on our ability to raise additional capital.

Enclomiphene

If you have questions about enclomiphene, please call Repros at 800-895-6554 ext 3403 or email studyinfo@reprosrx.com.


Ongoing Studies

Enclomiphene - Diet and Exercise Study (ZA-205) (Active)

Purpose: To compare the effects of treatment with enclomiphene to placebo, upon body composition and metabolic parameters in hypogonadal men undergoing a 6-month diet and 15 month exercise program.



Proellex®

If you have questions about Proellex, please call Repros at 800-895-6554 ext 3401 or email studyinfo@reprosrx.com.


Ongoing Studies

Proellex® - Extension Study for Treatment of Pre-Menopausal Women with Confirmed, Symptomatic Uterine Fibroids (ZPU-203EXT) (Active)

Purpose: To determine the safety of extended treatment with Proellex in women who have successfully completed either study ZPV-201 or ZPU-203 and meet eligibility criteria.

Proellex® - Treatment of Pre-Menopausal Women with Confirmed, Symptomatic Endometriosis (ZPE-202) (Active)

Purpose: To determine the safety and efficacy of two doses of Proellex in premenopausal women with pelvic pain in endometriosis confirmed within the last seven years and using prescription analgesics for symptomatic pain.

Proellex® - Treatment of Pre-Menopausal Women with Confirmed, Symptomatic Uterine Fibroids (ZPU-203) (Active)

Purpose: To determine the safety and efficacy of two oral doses of Proellex in premenopausal women with symptomatic uterine fibroids confirmed by MRI.

Proellex® - Treatment of Pre-Menopausal Women with Confirmed, Symptomatic Uterine Fibroids (ZPV-201) (Active)

Purpose: To determine the safety and efficacy of two vaginal doses of Proellex in premenopausal women with symptomatic uterine fibroids confirmed by MRI.

2408 Timberloch Place, B-7
The Woodlands, Texas 77380
281-719-3400
281-719-3446 fax